L. Prasannan et al., Parotid carcinoma as a second malignancy after treatment of childhood acute lymphoblastic leukemia, J PED H ONC, 21(6), 1999, pp. 535-538
The occurrence of second malignant neoplasms (SMN) in children who survive
their primary malignancy is a major cause for concern. Two children with di
agnoses of intermediate-risk acute lymphoblastic leukemia (ALL) at 22 month
s and 2 years of age were treated with multiagent chemotherapy and prophyla
ctic cranial irradiation. They experienced painless parotid swelling 6 and
7 years after successful treatment of the ALL. The patients underwent total
parotidectomy, and a diagnosis of mucoepidermoid carcinoma was made. Both
patients experienced transient facial nerve paresis. The incidence of SMN i
n children successfully treated for primary malignancies is 3% to 12%. Sali
vary gland tumors are being increasingly described in this setting. Long-te
rm followup for survivors of childhood ALL is recommended with prompt asses
sment and resection of parotid swellings, particularly in children who have
received cranial irradiation.